Manufacturers trying to put into practice these methods need to present strong validation data to show their equivalence to pharmacopoeial strategies. As these new systems arise, the WHO emphasizes the significance of an intensive chance assessment and validation course of action. Your requirements are our precedence: leverage the know-ho